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Articular cartilage and synovial joints are critical for skeletal function, but the mechanisms regulating their development are largely unknown.
In previous studies we found that the ets transcription factor ERG and its alternatively-spliced variant C-1-1 have roles in joint formation in chick.
Here, we extended our studies to mouse. We found that ERG is also expressed in developing mouse limb joints. To test regulation of ERG
expression, beads coated with the joint master regulator protein GDF-5 were implanted close to incipient joints in mouse limb explants; this led to
rapid and strong ectopic ERG expression. We cloned and characterized several mammalian ERG variants and expressed a human C-1-1
counterpart (hERG3Δ81) throughout the cartilaginous skeleton of transgenic mice, using Col2a1 gene promoter/enhancer sequences. The skeletal
phenotype was severe and neonatal lethal, and the transgenic mice were smaller than wild type littermates and their skeletons were largely
cartilaginous. Limb long bone anlagen were entirely composed of chondrocytes actively expressing collagen IX and aggrecan as well as articular
markers such as tenascin-C. Typical growth plates were absent and there was very low expression of maturation and hypertrophy markers,
including Indian hedgehog, collagen X and MMP-13. The results suggest that ERG is part of molecular mechanisms leading chondrocytes into a
permanent developmental path and become joint forming cells, and may do so by acting downstream of GDF-5.
© 2007 Elsevier Inc. All rights reserved.Keywords: ERG transcription factor; Articular chondrocytes; Limb and spine skeletogenesis; GDF-5; Extracellular matrixIntroduction
During limb skeletogenesis, chondrocytes follow two
developmental paths. The relatively few chondrocytes form-
ing at each epiphyseal end of long bone anlagen develop into
permanent articular chondrocytes. These cells exhibit a stable
phenotype, produce and deposit an abundant and resilient
extracellular matrix composed of aggrecan, collagen II and
other macromolecules, and maintain tissue and synovial joint
structure and function though life. Instead, the more
numerous chondrocytes constituting the metaphyseal and
diaphyseal portions of the long bone templates are transient⁎ Corresponding author. Fax: +1 215 955 9159.
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doi:10.1016/j.ydbio.2007.01.037cells, are organized in growth plates in which they undergo
proliferation, maturation, hypertrophy and major changes in
gene expression, and are eventually replaced by bone and
marrow cells via endochondral ossification. Growth plate
chondrocytes exert their roles up until the end of puberty at
which point they disappear upon completion of skeletal
growth. The critical importance of articular and growth plate
chondrocytes for skeletal organization, growth and function is
widely recognized and acknowledged, and both cell types
continue to attract strong research activity at the basic and
biomedical level (Archer et al., 1999; Kronenberg, 2003;
Lefebvre and Smits, 2005). On the other hand, the
mechanisms by which chondrocytes handle their develop-
mental choices at early embryonic stages and give rise to
permanent articular or transient growth plate cartilage remain
41M. Iwamoto et al. / Developmental Biology 305 (2007) 40–51largely unclear, particularly at the molecular level (Archer et
al., 2003; Pacifici et al., 2005).
ERG belongs to the ets gene family of transcription factors
(Sharrocks, 2001). The current 26 family members are involved
in a variety of cellular and developmental processes and when
mutated or mis-expressed, can cause pathologies (Muthusamy
et al., 1995; Sharrocks, 2001; Tondravi et al., 1997). Ets
proteins share a highly conserved 85-amino acid domain (the
ETS domain) that binds to the consensus DNA core sequence
5′-GGA(A/T)-3′ (Karim et al., 1990). Individual ets proteins
can select specific nucleotides over an 11 bp sequence centered
around the core sequence. Additional specificity is provided by
interactions with other transcription factors (Verger et al., 2001;
Verger and Duterque-Coquillaud, 2002), phosphorylation and
conformational changes consequent to interactions with other
factors (Papoutsopolou and Janknecht, 2000; Sharrocks, 2001;
Yang et al., 2001). The ETS domain is a variant of the winged
helix–turn–helix motif and displays three α-helices and four β-
sheets, with the main protein–DNA contacts provided by
residues located along the third α-helix. Though the ETS
domain is highly conserved with the family, ets proteins differ
from each other in other domains (such as absence or presence
of the Pointed/SAM domain) and are thus distinguished in sub-
families (Sharrocks, 2001; Verger and Duterque-Coquillaud,
2002).
ERG belongs to the Erg/Fli-1 sub-family. ERG has been
widely studied for its involvement in human cancers following
gene translocation to form fusion proteins (Shimizu et al.,
1993). ERG is also linked to normal processes such as
mesoderm formation (Vlaeminck-Guillem et al., 2000) and is
found to form functional complexes with Jun/Fos, with the
resulting ternary complexes regulating expression of genes such
as metalloprotease-1 (MMP-1) and MMP-3 (Buttice' et al.,
1996). Most relevant to the present study are the original studies
of Dhordain et al. providing the initial evidence that ERG is
expressed at sites of future synovial joint formation in chick
embryo limbs (Dhordain et al., 1995). These data were
confirmed and extended by Hurle and co-workers showing
that joint malformations provoked by ectopic expression of
transforming growth factor β-family members were associated
with defective ERG expression (Ganan et al., 1996). Following
the lead of these groups, we carried out additional studies in
chick embryos (Iwamoto et al., 2001; Iwamoto et al., 2000). We
found that ERG was not only expressed at the onset of joint
formation, but persisted once the articular layer had developed
further. Aware of the fact that ets proteins can be alternatively-
spliced (Duterque-Coquillaud et al., 1993), we carried out
additional analyses and cloned a variant missing an 81-bp
segment (exon 5) in the central portion of ERG. We named this
variant C-1-1 and found that it was preferentially, albeit not
exclusively, expressed in most epiphyseal pre-articular/articular
chondrocytes in developing long bones. When we mis-
expressed C-1-1 in developing chick limbs, we observed that
C-1-1 was able to impose a stable, immature and articular-like
phenotype onto the entire limb chondrocyte population,
effectively blocking maturation and endochondral ossification
(Iwamoto et al., 2000, 2001). These and other data led us toconclude that ERG is part of molecular mechanisms for joint
and articular cartilage formation in chick embryos.
The present study was conducted to extend our analyses to
mammalian systems, specifically to identify mammalian
counterpart(s) of avian C-1-1 and determine its biological
properties and roles during limb skeletogenesis. In addition, we
searched for upstream regulators that could induce and restrict
ERG gene expression to developing joint cells. We focused on
the bone morphogenetic protein family member GDF-5 that is
thought to represent a master regulator of joint formation (Storm
and Kingsley, 1999). GDF-5 expression is particularly promi-
nent in the interzone, a three-layered mesenchymal structure
that demarcates and constitutes the joint forming area and
whose cells are thought to give rise to joint tissues in developing
long bones (Holder, 1977; Ito and Kida, 2000). We describe
here the cloning of a human ERG variant homologous of avian
C-1-1 and its functional characterization by transgenic expres-
sion in the cartilages of mouse embryos using Col2a1 promoter/
enhancer sequences. We report also that there is close spatio-
temporal expression of both ERG and GDF-5 in developing
mouse embryo joints and that GDF-5 is a rapid and effective
inducer of ERG expression.
Materials and methods
Cloning of mammalian ERG variants
cDNA clones encoding mouse ERG variants were isolated from a E15.5
whole mouse embryo plasmid library (GibcoBRL) using Gene Trapper cDNA
Positive Selection System according to manufacturer's instructions. Briefly,
5 μg of double strand cDNA pool prepared from the cDNA library was digested
with Gene II polymerase and Exo III nuclease to generate single strand DNA
pool (ssDNA pool). The ssDNA pool was hybridized with a biotinylated
antisense mouse ERG oligo (5′-GCTGGAGTGGGCGGTGAAAGAATA-3′)
common to all variants. Hybridized DNAs captured by magnetic streptavidin
beads were converted to double strand DNA with gene-specific primer (5′-
GCCGACATTCTTCTCTCACATCTC-3′) and then used to transform DH10B
(GibcoBRL). After transformation, we carried out colony PCR with the primer
pair 5′-GGAGAGGAAGAGCAAGCCCAACAT-3′ and 5′-TCGGGGAAG-
CAAAGAAACTGGAA-3′ which amplify ets DNA binding domain; this
resulted in the identification of 19 ets-domain containing clones. Clones were
sequenced and their predicted structures are shown in Fig. 1A.
To obtain human ERG cDNA variants, we used a combination of 5′ and 3′
RACE techniques. We first constructed a library of adaptor-ligated double-
strand cDNAs with total RNA from fetal brain and cartilage (kindly provided by
Dr. J. Miki, Tsukuba, Japan) using the Marathon cDNA amplification kit
according to the manufacturer's protocol (Clontech, Palo Alto, CA). The library
was used as a template for 3′- and 5′-RACE reactions. We first performed 3′-
RACE reaction with adaptor primer (AP1) included in the kit and with a gene
specific primer (5′-GAGAGCGGAAGAGCAAACCCAACA-3′) designed
within ets-DNA binding domain of human ERG2 (M17254) (Rao et al.,
1987). We then performed 5′-RACE reaction with AP1 primer and a gene
specific primer (5′-TCATCTTGCACAGTTCCTTCCCATC-3′) designed
within the SAM domain. PCR amplified 3′ and 5′ RACE products were
subcloned into pGEM-T vector (Promega) and sequenced. Entire coding
sequences of hERG3 and hERG3Δ81 were then amplified by PCR with 5′-
GACATGATTCAGACTGTCCCGG-3′ and 5′-CCGCCAGGTCTTTAGTAG-
TAAGTGC-3′ and subcloned to pGEM-T vector.
Construction of recombinant retroviral vectors
Entire coding sequences of mERG, mERGΔ72 and mERGΔ69 were
amplified by PCR from respective cDNA templates DNA using gene
Fig. 1. Schematic of chick, mouse and human ERG variants and analyses of biological activities. (A) Only major variants are shown in this scheme. Note the sterile
alpha motif (SAM)/Pointed domain; the variable region (V) containing 81, 72 and/or 69 bp exons; and the DNA binding ETS domain. (B) RT-PCR analysis of tenascin
C (TN-C), collagen X (X) and HPRT expression in chick chondrocytes at 1 and 3 weeks of culture that over-expressed indicated mouse or human ERG variants (lanes
3–7). Insert-less virus was used to infect control cells (lanes 1–2). (C) APase activity in 3-week-old chondrocyte cultures infected with control insert-less virus or
viruses encoding indicated mouse or human ERG variants. APase activity was normalized to DNA contents and is expressed as the average of three independent
cultures ±S.D.
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CCTAGTAGTAGGTGCCCAGGTGAGAGG-3′, subcloned to pGEM-T vec-
tor and sequenced. Full length mouse and human ERG variants in pGEM-T
vector were released by SpeI and NotI digestion and subcloned into SpeI/
NotI sites of RCASBP(B)L-44 vector (Iwamoto et al., 2003). Dermal
chicken embryo fibroblasts from virus-free white leghorn 11-day-old
embryos (SPAFAS) were cultured in medium 199 containing 10% fetal
bovine serum and transfected with retroviral plasmid vectors by use of
FuGENE6 transfection reagent (Roche Diagnostic Inc). Recombinant viral
particles present in the medium were concentrated by ultracentrifugation
(25,000 rpm for 3 h) and used to infect freshly isolated chondrocytes. By 1
and 3 weeks of culture, over 90% of the chondrocytes were infected as
revealed by immunostaining for viral coat protein (Iwamoto et al., 2003).
Insert-less control viral particles were produced and isolated in the same
manner. Immature chondrocytes from the caudal portion of Day 17 chick
embryo sterna were cultured in high-glucose DMEM containing 10% FBS.
Culture medium was changed every other day after day 5 and cells were
passaged weekly. At 1 and 3 weeks in culture, total RNA was collected by
Trizol and used for RT-PCR analysis using primer pairs described
previously (Iwamoto et al., 2003). APase activity associated with the celllayer was measured using p-nitrophenyl phosphate (pNP) as a substrate
(Iwamoto et al., 2003).
Generation of transgenic mice
DNA fragments encoding an entire coding sequence of hERG3Δ81 were
excised from pGEM-T vector by SpeI/NotI digestion and cloned into the NotI
site of a Col2a1-based expression vector by blunt end (Ueta et al., 2001).
Synthetic NarI site was introduced into a HindIII site of the above vector. The
resulting vector contains hERG3Δ81 expression unit including 5′-NarI site-
Col2a1 promoter (nucleotide 1940–2971 of M65161), β-globin intron cassette,
CA-LEF, SV40 poly A, Col2a1 enhancer (4930–5571 of M65161), NarI site-3′
in pNASSβ backbone (Clontech, California, USA). The expression unit of
hERG3Δ81 was excised by NarI digestion, purified and injected into pronuclei
of fertilized eggs from F1 hybrid mice (C57BL/6 X C3H). Transgenic embryos
were identified by PCR and immunohistochemistry. Genomic DNA was
prepared from liver tissue and subjected to PCR using primers 5′-TGG-
TCATCATCCTGCCTTTCTC-3′ and 5′-GGAAGTCATCCTTTGT-
CATCTTGC-3′ TGC AGC TTT ATC CAG GCT GGT CAG-3′ and 5′-CAC
CCATCT CAT GCT CCATCATCATAG G-3′ that amplify 316 bp fragment
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level was analyzed by immunostaining with anti-human ERG antibody (ERG-
1//2/3 (C-20), sc-353)(Santa Cruz Biotechnology, CA) (Iwamoto et al., 2000).
Sixty six out of 577 embryos were transgene positive by PCR genotyping, and
transgene over-expression was observed in 11 embryos that were examined in
the present study.
Anatomical, histological and immunohistochemical analyses
Whole skeletons of E18.5 embryos were stained with alizarin red S and
alcian blue (Ueta et al., 2001). MicroCTanalysis was carried out by a centralized
facility, using a Scanco μCT40 apparatus. For histology, E18.5 tissues fixed in
4% paraformaldehyde/0.1 M phosphate buffer were embedded in paraffin and
sections stained with hematoxylin and eosin. For immunohistochemistry,
sections were de-masked by treatment with 0.2% pepsin in 0.02N HCl for
15 min at 37 °C, and were incubated with rabbit anti-mouse tenascin-C antibody
(Ueta et al., 2001) or rabbit anti-human ERG (Santa Cruz Biotechnology) for
16 h at 4 °C. The ERG antibodies react with every ERG variant. After rinsing,
sections were incubated with biotinylated anti-rabbit IgG (Vector Laboratories,
Inc., Burlingame, CA) and Cy3-conjugated Streptavidin (Jackson ImmunoR-
esearch Laboratories, Inc., West Grove, PA); each incubation was for 30 min at
room temperature.
Explant cultures
Autopods were isolated from E12.5–E13.5 mouse embryos and day 5.5
chick embryos and placed in standard serum free organ cultures. At the moment
of isolation, specimens displayed cartilaginous primordia of digits. A single
heparin Sepharose bead presoaked for 1 hr with recombinant GDF-5 (10 μg/ml)
was microsurgically implanted in proximity of the cartilaginous elements;
companion specimens received a bead precoated with BSA as control (Koyama
et al., 1999). All samples were incubated for 6 to 24 h and were then processed
for whole mount detection of ERG expression (Shimo et al., 2005), using full
length chick or mouse ERG probes that react with every variant as described
(Iwamoto et al., 2000).
In situ hybridization
Tissue section in situ hybridization was carried out using digoxigenin-
conjugated or 35S- or 33P-labeled riboprobes (Iwamoto et al., 2000; Ueta et al.,
2001). pGEM-T vector encoding full length mERG was used to generate
riboprobes common to all mouse ERG variants. PGEM-T vectors encoding
GDF-5 (1321–1871 of NM_008109) and PRG4/Lubricin (41–2646 of
AB034730) were used to generate respective probes. MMP-13 and other
probes were as described (Jimenez et al., 1999; Tamamura et al., 2005).
Results
Cloning and characterization of mammalian ERG variants
Chick, mouse and human ERG genes have similar structure
and organization. Each gene is transcribed from two transcrip-
tional start sites and the alternative use of 3 exons in the
variable (V) region (81, 69 and 72 bp long, respectively)
generates multiple variants (Fig. 1) (Duterque-Coquillaud et al.,
1993; Rao et al., 1987). As detailed in our previous studies
(Iwamoto et al., 2000, 2001), two main ERG variants are
expressed in developing chick limbs: chERG that contains all 3
exons of the V region; and C-1-1 that lacks the 81 bp segment
(Fig. 1A). To identify ERG variants expressed in mouse, we
screened mouse embryo cDNA libraries and cloned several
ERG variants including: (i) mERG corresponding to chERG;
(ii) mERGΔ72 that lacks the 72 bp segment; and (iii)mERGΔ69 that lacks the 69 bp segment (Fig. 1A). Three
other variants containing a longer 5′ un-translated region
(AB073078, AB073079 and AB073080) had previously been
deposited in the NCBI database. Thus, our screens did not lead
to the identification of a mouse homologous of chick C-1-1
lacking the 81 bp only.
In concurrent studies, we made use of 5′ and 3′ RACE
procedures with cDNA templates prepared with RNA from
human cartilage and brain to characterize human ERG variants.
Clones were sequenced and used to design new primers for
amplification and cloning of the entire coding sequences. These
approaches led us to identify several human ERG variants
including: (i) hERG corresponding to chERG and mERG; (ii)
hERG3 containing a longer 5′ un-translated region and
corresponding to mERG3; and (iii) hERG3Δ81 that lacks the
81 bp segment and is thus similar to C-1-1 in its coding region,
but contains a longer 5′ un-translated region (Fig. 1A).
As an initial characterization of functional properties of
mouse and human ERG variants, we constructed avian
retroviral RCAS expression vectors encoding mERG,
mERGΔ72, mERGΔ69, hERG3 or hERG3Δ81 and tested
each construct in primary cultures of chick sternum chondro-
cytes, a widely used system that permits rapid and effective
evaluation of transgene effects on chondrocyte phenotype and
maturation (Gibson and Flint, 1985; Iwamoto et al., 1993).
Aliquots of freshly isolated chondrocytes were infected with
each of the RCAS viruses and plated in standard monolayer
cultures; companion control cells received equal amounts of
insert-less RCAS virus. After 1 week of culture, the control
cells displayed a characteristic and relatively small cell size,
strong gene expression of tenascin-C (TN-C) that is a marker of
permanent and articular chondrocytes (Pacifici et al., 1993;
Savarese et al., 1996), and very low and barely detectable
expression of collagen X which is a marker of maturing
hypertrophic chondrocytes (Fig. 1B, lane 1). By 3 weeks, TN-
C expression had become undetectable and collagen X had
increased significantly (Fig. 1B, lane 2) and the cells had
increased in size (not shown), traits indicating that the cells
were undergoing maturation and hypertrophy. When we
examined 3-week-old cultures over-expressing RCAS-encoded
mammalian ERG variants, none expressed collagen X at
appreciable levels and each of them strongly expressed TN-C
(Fig. 1B, lanes 3–7). We also measured alkaline phosphatase
(APase) activity that is another marker of chondrocyte
maturation and hypertrophy. Whereas APase activity was
strong and easily detectable in 3-week-old control cultures,
APase activity was consistently low in each mammalian ERG
over-expressing culture (Fig. 1C). Together, the data indicate
that mouse or human ERG variants have similar activities,
stabilize chondrocyte function, inhibit chondrocyte progression
toward maturation and thus favor a permanent articular-like
phenotype.
ERG expression in developing mouse embryo limbs
The above conclusion implies that mammalian ERG
should be expressed in developing permanent chondrocytes
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hybridization analyses using serial longitudinal sections of
E13.5 to E18.5 mouse embryo hind limbs. Sections were
hybridized with riboprobes encoding: (a) full-length mERG
recognizing every variant; (b) collagen IX that is a major
cartilage matrix component and a typical phenotypic trait of
functional chondrocytes; and (c) GDF-5 and lubricin/PRG4
that are markers of developing joint and articular chondro-
cytes (Rhee et al., 2005; Schumacher et al., 1994; Storm and
Kingsley, 1999). In E13.5 embryos, the incipient knee joint
was fairly well organized and the flanking tibia and femur
elements were fully cartilaginous, and the more distal tarsal
and phalageal joints and skeletal elements were developmen-
tally younger (Fig. 2A). ERG expression was prominent in
developing knee joint (Fig. 2B, arrow) and incipient tarsal–
phalangeal joints (Fig. 2B, arrowheads). GDF-5 was
expressed in essentially super-imposable patterns (Fig. 2C,
arrow and arrowheads, respectively). By E15.5, ERG and
GDF-5 continued to exhibit comparable, preferential and
quite strong expression in every limb joint, including distal
tibial, ankle and phalangeal joints (Figs. 2D–E). By E18.5,
gene expression of ERG and GDF-5 was somewhat lower,
but had become more clearly localized to the 5 or 6 layers of
articulating chondrocytes abutting the synovial cavities (Figs.
2G–I, arrowheads), a finding quite evident when viewed atFig. 2. ERG is expressed in developing mouse limb joints. Serial sections of hind l
hybridized with radio-labeled riboprobes encoding ERG, GDF-5, collagen IX or lub
joints and its expression is quite similar to that of GDF-5. By E18.5, ERG expression
express also lubricin/PRG4 (M–N). Bar for panels A–J, 1 mm; and bar for panels Khigher magnification (Figs. 2K–L). The same ERG-positive
articulating chondrocytes strongly expressed lubricin (Figs.
2M–N), attesting to the fact that they were acquiring and
displaying characteristics of functional articular chondrocytes.
ERG expression patterns were quite distinct from those of
collagen IX that instead characterized the entire cartilaginous
portions of limb elements (Fig. 2J).
To determine whether ERG is expressed in other joints, we
examined the developing spine. Indeed, ERG as well as GDF-5
were strongly co-expressed in nascent inter-vertebral joints and
more specifically in developing annulus fibrous (a permanent
fibro-cartilage structure) and endplates (Figs. 3A–F, arrows).
ERG induction by GDF-5
Given that ERG expression is closely associated with GDF-
5 expression, it is possible that GDF-5 may actually induce/
regulate ERG expression. To test this hypothesis, we isolated
autopods (paws/feet) from E12.5–13.5 mouse embryos and
Day 5.5 chick embryos and placed them in organ culture.
These explants grow well in medium-defined conditions and
continue their development over time. At the moment of
isolation, both murine and avian specimens contain cartilagi-
nous templates of digits that are still largely un-interrupted at
each future joint site; joint formation continues over time inimbs from E13.5 (A–C), E15.5 (D–F) and E18.5 (G–N) mouse embryos were
ricin/PRG4. Note at E13.5 and E15.5 (A–F) that ERG is expressed in nascent
is lower and restricted to most-epiphyseal articular chondrocytes (H and L) that
–N, 100 μm.
Fig. 4. GDF-5 induces ectopic ERG expression. Day 5.5 chick embryo and
E12.5 mouse embryo autopods were placed in organ culture and implanted
microsurgically with a single Sepharose-heparin bead pre-soaked with BSA or
GDF-5 (10 μg/ml). Specimens were maintained for 6 h and then processed for
whole mount hybridization for ERG expression. Positive ERG signal is purple
and can be seen surrounding each GDF-5 bead (B and D, arrowheads) but not
around control BSA beads (A and C).
Fig. 3. ERG and GDF-5 are co-expressed in developing intervertebral discs.
Serial sagittal sections of E15.5 mouse embryos were hybridized with ERG (A–
D) or GDF-5 (E–F) riboprobes and examined at low (A–B) and high (C–F)
magnification. Arrowheads point to the strong ERG and GDF-5 hybridization
signal visible in the annulus fibrosus in each disc. Bar for panels A–B, 1 mm;
and bar for panels C–F, 200 μm.
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GDF-5 (10 μg/ml) was microsurgically implanted in proximity
of incipient metatarsal–phalangeal joints; companion control
specimens received a bead pre-coated with vehicle (BSA).
Cultures were re-incubated and examined over time from bead
implantation by whole mount in situ hybridization. Indeed,
within 6 h of treatment, strong ERG expression visible as a
purple hybridization signal was induced around the GDF-5
soaked bead (Figs. 4B, D, arrows); control beads had no effect
(Figs. 4A, C). Strong ERG expression persisted at the other
time points examined (not shown).
Transgenic analysis of mammalian ERG properties
To further characterize the biological properties of mamma-
lian ERG, we created transgenic mice expressing hERG3Δ81in developing cartilage under the control of mouse Col2a1
promoter/enhancer sequences. We focused on this human
variant since it is the one most closely resembling avian C-1-1;
the Col2a1 sequences are the ones we previously used to
express isoforms of transcription factor Runx2 in the develop-
ing cartilaginous skeleton of transgenic mice (Ueta et al.,
2001). Constructs were microinjected into the pronuclei of
fertilized eggs by a centralized facility, and a total of 11
transgenic F0 mouse embryos were obtained and identified by
presence of transgene DNA in cartilage (five embryos were
examined by histology, histochemistry and in situ hybridiza-
tion; 4 embryos were examined by alcian blue/alizarin red
staining; and 1 embryo was subjected to soft X-ray and μCT
analysis). To verify transgene expression, sections of E18.5
wild type and transgenic limb cartilages were processed for
immunostaining with an ERG antiserum that recognizes every
variant. Endogenous ERG protein in wild type tibias was
visible in most epiphyseal articulating chondrocytes (Fig. 5A,
arrows) and peri-epiphyseal perichondrium (Fig. 5A, arrow-
heads) as expected, whereas ERG was widespread in transgenic
tibial chondrocytes (Fig. 5B). Higher magnification view
showed that ERG staining was largely restricted to the nucleus
(Fig. 5A, inset) and that the majority of the transgenic
chondrocytes were positive (Fig. 5B inset). Not all chondro-
cytes were positive since the F0 embryos used here were most
likely mosaic.
Mice over-expressing hERG3Δ81 died at birth from respiratory
failure. As exemplified by analysis of E18.5 embryos stained with
alizarin red and alcian blue, the transgenic embryos were much
smaller and their trunk and limb skeletal elements were hypo-
Fig. 5. ERG is widespread in transgenic cartilage. Tibias from E18.5 wild type and hERGΔ81 transgenic embryos were processed for ERG immunostaining, using
antibodies that recognize each variant. Note in panel A that ERG is most appreciable at the epiphyseal ends in wild type tissue (arrows) and peri-epiphyseal
perichondrium (arrowheads), whereas it is widespread throughout the transgenic cartilage tissue (B). Inset in panel A is a higher magnification view of boxed area
showing that ERG is largely nuclear. Inset in panel B shows that many but not all transgenic chondrocytes contain nuclear ERG, a reflection of the likely mosaicism of
the transgenic mice.
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compared to wild type littermates (Fig. 6A). Soft X-ray analysis
confirmed the reduced levels of mineralization in transgenic
vertebral column, ribs and limbs (Figs. 6E–F) relative to wild type
(Figs. 6B–C). In addition, the transgenic cranium was smaller than
wild type.
Serial sections of wild type and transgenic forelimbs were
processed for histology to analyze the phenotype, maturation
process and growth plate organization. Wild type E18.5 long
bones such as the humerus displayed a typical structure
consisting of a prominent epiphyseal cartilaginous cap (where
a secondary ossification center will eventually form) and a well-
organized growth plate in the metaphysis (Figs. 7A, C). Instead,
the transgenic humerus was disorganized (Figs. 7B, D). The
epiphyseal and metaphyseal portions consisted of a uniform
cartilaginous tissue in which the chondrocytes, regardless of
location, had a small and fairly uniform diameter and were not
organized in a typical growth plate (Figs. 7B, D). The
diaphyseal portion contained bone-like tissue, but the tissue
appeared fibrotic and very poor in marrow (Fig. 7D). To extendFig. 6. Transgenic hERGΔ81 expression in cartilage leads to dwarfism. Skeletons of
staining with alizarin red and alcian blue (A and D) or subjected to soft X-ray analy
smaller than wild type littermates and exhibit higher overall amounts of cartilagino
transgenic mice are hypo-mineralized (E–F) compared to control (B–C).these observations, sections were stained with the proteoglycan
matrix dye Safranin-O. This histochemical procedure showed
that in wild type humerus the transition from hypertrophic
cartilage to endochondral bone was gradual, and long stands of
positively-staining hypertrophic cartilage intermingled with
marrow and bone trabeculae forming a primary spongiosa (Figs.
7E, G, arrowheads) as expected (Poole et al., 1982). In contrast,
the transition from cartilage to fibrous/bony tissue in transgenic
humerus was abrupt and there was no obvious intermingling of
cartilage with underlying tissues and virtual lack of primary
spongiosa (Figs. 7F, H). Analysis by μCT of companion
specimens fully confirmed these observations (Figs. 7I–J).
Clear strands of mineralized tissue occupied the metaphyseal–
diaphyseal region of wild humerus (Fig. 7I, arrowheads), but no
such strands were visible in transgenic humerus (Fig. 7J).
Interestingly, the cortical bone was essentially unaffected and
quite similar to wild type (Figs. 7I–J).
To characterize the chondrocyte phenotype, serial sections
were processed for in situ hybridization. Gene expression of
typical chondrocyte markers such as aggrecan and collagenE18.5 wild type (A–C) and transgenic (D–F) mouse embryos were processed for
sis (B–C and E–F). Note in panels A and D that the transgenic mice are much
us tissue and lower amounts of alizarin red-staining tissue. Note also that the
Fig. 7. Growth plate organization and ossification patterns are abnormal in
transgenic mice. Humeri from E18.5 transgenic embryos and wild type
littermates were processed for histology (A–D), histochemical detection of
proteoglycan matrix by Safranin O staining (E–H) and μCT analysis (I–J).
Transgenic cartilaginous elements lack a growth plate organization (B and D)
that is readily recognizable in wild type (A and C). Note also that there is a
typical gradual transition from hypertrophic cartilage to bone and presence of
primary spongiosa in wild type (E, G and I, arrowheads), whereas there is a
sharp boundary, no gradual transition and minimal primary spongiosa in
transgenic tissue (F, H and J).
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indicating that the transgenic cells were functional and were
not experiencing unexpected negative effects due to
transgene expression (Figs. 8A–B and F–G). However,
expression of markers of chondrocyte maturation and
hypertrophy, including Indian hedgehog (Ihh), collagen X
and MMP-13, were all markedly reduced in transgenic
(Figs. 8H–J) versus wild type (Figs. 8C–E). In good
correlation, the transgenic chondrocytes expressed the
articular chondrocyte marker tenascin-C broadly and strongly
(Fig. 9B), whereas this protein was expressed in epiphyseal
chondrocytes, bone and periosteum in wild type humerus as
expected (Fig. 9A).Discussion
In this study, we demonstrate that ERG expression
characterizes developing synovial joints in mouse embryo
limbs as we previously found in chick. The factor is initially
expressed in the murine mesenchymal interzone, and expression
continues in epiphyseal pre-articular/articular chondrocytes
over increasing developmental time. ERG is co-expressed
with the master joint regulator GDF-5 in limbs as well as in
intervertebral joints, and we show that GDF-5 is actually a rapid
inducer of ERG expression. Transgenic analysis reveals that
human ERG maintains chondrocytes in a differentiated state
characterized by strong expression of aggrecan, collagen IX and
tenascin-C, but inhibits their progression toward hypertrophy
and their organization into growth plates. Together, the data
provide further support for the conclusion (Iwamoto et al., 2000,
2001) that ERG is an important component of mechanisms of
synovial joint formation and would in particular act to regulate
the developmental behavior of most-epiphyseal chondrocytes
and help them to acquire a permanent articular chondrocyte
phenotype.
ERG and its variants
Given that ERG and other ets family members are known to
be expressed in alternatively-spliced forms (Duterque-Coquil-
laud et al., 1993; Sharrocks, 2001), it is not surprising that we
cloned several ERG variants from mouse and human tissues.
The hERG3Δ81 variant lacks a 81 bp domain (corresponding to
exon 5) in the V protein region and thus resembles avian C-1-1,
though it contains a longer 5′ un-translated region likely due to
usage of the upstream transcription start site. A homologue of
C-1-1/hERG3Δ81 was previously cloned and characterized in
Xenopous (Baltizinger et al., 1999) and thus this variant appears
to be widely expressed across species. Our failure to clone a C-
1-1-like variant in mouse could reflect extremely low expres-
sion levels, expression in very selected tissues or specific
developmental times, or simply absence of such variant in that
species. We have not clarified yet which specific variant or
variants are endogenously expressed in mouse embryo joints,
whether variants expressed in the limbs are identical to those
expressed in vertebral joints and tracheal rings, and whether
specific variants are induced by GDF-5. Based on our in vitro
data, it appears that each mammalian variant exerts similar
biological activities in chondrocytes. Given such similar
biological properties, it may actually not matter much whether
specific variant(s) is/are expressed in developing mammalian
joints since each variant would be able to contribute to
establishment of a permanent chondrocyte phenotype. This
conclusion is somewhat at variance with observations and
conclusions in our previous study in chick where we observed
that C-1-1 is preferentially expressed in developing epiphyseal
chondrocytes and has stronger stabilizing and anti-maturation
properties than chERG when over-expressed (Iwamoto et al.,
2000). One possible interpretation is that inclusion or exclusion
of the 81 bp domain in chick ERG may have more profound
effects due to chick-specific collateral contributions by other
Fig. 8. Gene expression of maturation markers is markedly reduced in transgenic growth plates. Sections from the distal half of E18.5 wild type (A–E) and transgenic
(F–J) humeri were hybridized with digoxigenin-labeled cDNA probes encoding: aggrecan (A, F); collagen IX (B, G); Indian hedgehog (C, H); collagen X (D, I); and
MMP13 (E, J). Note that aggrecan and collagen IX expression are equally strong in wild type and transgenic cartilage, whereas expression of maturation markers is
markedly lower in transgenic tissue. Sections in panels A–D and F–I are serial sections, whereas those in panels E and J are from other tissue blocks. Bar, 100 μm.
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expresses C-1-1 and chERG only, these two variants may need
to have more distinct bioactivities and provide a range of
functions needed in other tissues and stages. We should point
out also that in developing chick long bones, C-1-1 and chERG
are expressed not only in epiphyseal chondrocytes but also inthe pre-hypertrophic zone of growth plate (albeit at different
ratios), whereas ERG is largely if not exclusively restricted to
epiphyseal chondrocytes in mouse. By exhibiting a more
restricted gene expression pattern, mouse ERG may mostly be
involved in behavior and developmental fate of epiphyseal
chondrocytes and the apparent biological similarity of mouse
Fig. 9. Tenascin-C is widespread in transgenic cartilage. Sections from E18.5
wild type (A) and transgenic (B) tibias were de-masked and processed for
immunostaining with tenascin-C antibodies. Note that the protein is limited to
the epiphyseal end in wild type long bone anlaga as expected (A), whereas it is
present throughout the transgenic cartilage (B).
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joint-associated function.
ERG and GDF-5
An interesting outcome of the present study is the evidence
that GDF-5 is a rapid and effective inducer of ectopic ERG.
Since ERG and GDF-5 exhibit virtually super-imposable spatio-
temporal expression patterns, it is quite conceivable that GDF-5
may normally act to induce endogenous ERG. This is a likely
and reasonable possibility given that GDF-5 is a very important
regulator of synovial joint formation. Indeed, Kingsley and
coworkers originally showed that joint defects seen in digits,
wrist, ankle and other sites in the natural mouse mutant bra-
chypodism are due to lack of GDF-5 (Storm et al., 1994). In a
more recent study, the same group showed that compound
ablation of GDF-5 and GDF-6 genes causes widespread joint
defects and skeletal growth retardation (Settle et al., 2003).
What has remained unclear, however, is the exact roles that
GDFs and GDF-5 in particular have in joint formation. We may
now surmise that an important and possibly critical function of
GDF-5 would be to induce ERG and sustain the formation of
permanent chondrocytes.
Admittedly, the above conclusion is a bit rudimentary when
considered within the overall context of synovial joint
formation, with its many steps and evens, its sheer complexity,
and the many genes expressed (Archer et al., 2003; Pacifici et
al., 2005). In addition to ERG, GDF-5 and GDF-6, developing
joints express several other genes, including Wnt 14, Cux 1,
Barx1, CD44, Chordin and Stanniocalcin (Guo et al., 2004;
Hartmann and Tabin, 2001; Lizarraga et al., 2002; Stasko and
Wagner, 2001). An intriguing feature is that some of these genes
are chondrogenic and others are anti-chondrogenic. There have
been several attempts to explain these opposing biological
properties and how they would contribute to joint formation
(Archer et al., 2003; Pacifici et al., 2005). An emerging view is
that the anti-chondrogenic genes such as Wnt-14, Chordin and
Cux 1, could be needed at early stages to define and maintain
the mesenchymal character of the interzone. This would be
particularly important for the central layer of the interzone that
has pivotal functions, including cavitation and creation of a
synovial space (Ito and Kida, 2000). On the other hand, the
chondrogenic genes, including the GDFs, could act on interzone
cells adjacent to the epiphyseal ends and favor their differentia-tion into chondrocytes. This would contribute to emergence of
permanent articular chondrocytes. In this scenario, then, the
ability of GDF-5 to trigger ERG expression would be quite
important as it would allow newly-emerged chondrocytes to
remain permanent, avoid their inclusion in the growth plate and
maturation process, and establish the articulating ends of the
long bones.
Growth plate and bone
The bulk of long bone cartilaginous anlagen is eventually
replaced by bone tissue. This ossification process is closely
related to the function of the growth plate and involves the
initial formation of an intramembranous bone collar around the
diaphysis followed by formation of endochondral bone and
marrow replacing hypertrophic cartilage within the diaphysis
(Olsen et al., 2000). It is quite well established that these
ossification processes are closely dependent on, and tightly
regulated by, the growth plate. Specifically, the bone collar is
induced in conjunction with the pre-hypertrophic zone that
produces the osteogenic factor Indian hedgehog (Koyama et al.,
1996; Nakamura et al., 1997) and the endochondral bone
requires functioning hypertrophic chondrocytes (Engsig et al.,
2000; Komori et al., 1997; Koyama et al., 1999; Ueta et al.,
2001). Given the above, it is reasonable that by lacking typical
growth plates, the hERG3Δ81 transgenic mice would also
exhibit considerable bone defects. As shown by our histochem-
ical and μCT analyses, the trabecular bone/primary spongiosa
within the diaphysis are particularly affected and largely absent,
whereas the cortical bone appears to be less affected. One
interpretation of these intriguing results is that formation of
cortical bone may have been induced and sustained by Indian
hedgehog that was still expressed in the transgenic mice, though
at much reduced levels. Thus, defect in the diaphyseal
trabecular bone/primary spongiosa region and the sharp
transition we observe from cartilaginous tissue to intra-
diaphyseal fibrotic tissue would be due to absence of
functioning hypertrophic chondrocytes and lack of products
the cells produce to permit and sustain endochondral ossifica-
tion, including VEGF, MMP-9 and MMP-13 (Engsig et al.,
2000; Vu and Werb, 2000).
Clinical relevance
Despite their durability and resilience, articular chondro-
cytes are prone to malfunction and even deterioration, and this
is particularly evident in elderly individuals and osteoarthritic
patients (Brandt, 2004). Several studies have shown that a
significant number of osteoarthritic articular chondrocytes
undergo a maturation-like process and express traits typical
of growth plate cells, including an hypertrophic cell size,
collagen X and APase activity (Kirsch et al., 2000; von der
Mark et al., 1992). This progression toward maturation is
inexorable and eventually leads to the complete disruption of
articular cartilage and loss of joint function. We do not know
yet whether this progression involves a loss of ERG expression
or function, but this is certainly a plausible scenario. It is
50 M. Iwamoto et al. / Developmental Biology 305 (2007) 40–51known that progression of chondrocyte maturation requires
action by another transcription factor, Runx-2 (Komori et al.,
1997). In a recent study, we directly compared the biological
properties of Runx-2 and ERG in cultured chick chondrocytes
(Iwamoto et al., 2005). We found that virally-driven Runx2-
over-expression led to rapid chondrocyte maturation and a
marked down-regulation of endogenous C-1-1 expression,
while C-1-1 over-expression maintained the cells in an
immature articular-like status without major rapid changes in
endogenous Runx2 expression. The data suggest that when
expressed at sufficiently high levels, each of these factors can
have a dominant effect on the chondrocyte phenotype. It will
thus be interesting and of medical relevance to establish in the
future if ERG could be used as a therapeutic means to restore
function and a permanent-like status on malfunctioning or
aging articular chondrocytes. Given the biological potency of
the mammalian variants shown here, this is a possibility well
worth pursuing.
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